MTOR and hepatocellular carcinoma: Dysfunction of hepatic TSC1, a suppressor of mTOR signaling, occurs in patients with hepatitis B, hepatitis C or insulin resistance, which is a risk factor for HCC development (Lee et al., 2008; Totoki et al., 2011; Yen et al., 2012; Ho et al., 2017).